Compare PAHC & FOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAHC | FOR |
|---|---|---|
| Founded | 1946 | 2005 |
| Country | United States | United States |
| Employees | 2475 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2014 | 2007 |
| Metric | PAHC | FOR |
|---|---|---|
| Price | $33.72 | $29.75 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $41.25 | $32.67 |
| AVG Volume (30 Days) | ★ 277.6K | 137.7K |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | ★ 1883.33 | N/A |
| EPS | ★ 1.90 | 0.93 |
| Revenue | $833,350,000.00 | ★ $1,662,400,000.00 |
| Revenue This Year | $17.03 | $0.34 |
| Revenue Next Year | $3.82 | $7.73 |
| P/E Ratio | ★ $18.18 | $33.12 |
| Revenue Growth | 4.12 | ★ 10.14 |
| 52 Week Low | $25.58 | $21.78 |
| 52 Week High | $60.08 | $32.06 |
| Indicator | PAHC | FOR |
|---|---|---|
| Relative Strength Index (RSI) | 51.33 | 49.23 |
| Support Level | $30.46 | $29.42 |
| Resistance Level | $34.57 | $30.74 |
| Average True Range (ATR) | 1.30 | 0.89 |
| MACD | 0.44 | -0.18 |
| Stochastic Oscillator | 67.13 | 13.64 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. The company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.